title: Cardiopulmonary bypass elicits a prominent innate immune response in children with congenital heart disease.
authors.affiliation: Department of Intensive Care, Royal Children's Hospital, Parkville, Victoria, Australia.
authors.forename: Christian F
authors.initials: CF
authors.lastname: Stocker
authors.forename: Lara S
authors.initials: LS
authors.lastname: Shekerdemian
authors.forename: Kumar
authors.initials: K
authors.lastname: Visvanathan
authors.forename: Narelle
authors.initials: N
authors.lastname: Skinner
authors.forename: Christian P
authors.initials: CP
authors.lastname: Brizard
authors.forename: John B
authors.initials: JB
authors.lastname: Carlin
authors.forename: Steven B
authors.initials: SB
authors.lastname: Horton
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Penny
mesh_terms: D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007113:Immunity, Innate; D007223:Infant; D015850:Interleukin-6 / Q000097:blood; D008562:Membrane Glycoproteins / Q000097:blood; D011956:Receptors, Cell Surface / Q000097:blood; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000276:immunology*; D051193:Toll-Like Receptors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D015850:Interleukin-6; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors; D014409:Tumor Necrosis Factor-alpha